2022
Exports | Imports
$310M | $4.71BWorld Rnk 30 / 208
Flag Rnk 102 / 1206
World Rnk 16 / 225
Flag Rnk 12 / 1198
2022
ECONOMIC COMPLEXITY of Brazil
0.29Rnk 49 / 124
2022
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.47Rnk 46 / 1025

About

Exports In 2022, Brazil exported $310M in Vaccines, blood, antisera, toxins and cultures, making it the 30th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 102nd most exported product in Brazil. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Brazil are: China ($151M), Uruguay ($21.4M), United Kingdom ($19.9M), Germany ($9.72M), and Paraguay ($7.9M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Brazil between 2021 and 2022 were China ($149M), Uruguay ($14.7M), and Japan ($7.62M).

Imports In 2022, Brazil imported $4.71B in Vaccines, blood, antisera, toxins and cultures, becoming the 16th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 12th most imported product in Brazil. Brazil imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($1.11B), Switzerland ($717M), United States ($702M), Germany ($526M), and Ireland ($336M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Brazil between 2021 and 2022 were Germany ($344M), Belgium ($318M), and Argentina ($150M).

COMPANIES In 2023, leading companies such as were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from Brazil to the United States.

Latest Trends

February 2024

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (February 2023 - February 2024)$-2.53M(-34%)
IMPORT GROWTH (February 2023 - February 2024)$-114M(-20%)
MAIN EXPORTER (February 2024)São Paulo$4.02M
MAIN DESTINATION (February 2024)United Kingdom$904k

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Brazil. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$310M
IMPORTS (2022)$4.71B
NET TRADE (2022)-$4.4B

In 2022, Brazil exported $310M in Vaccines, blood, antisera, toxins and cultures. The main destinations of Brazil exports on Vaccines, blood, antisera, toxins and cultures were China ($151M), Uruguay ($21.4M), United Kingdom ($19.9M), Germany ($9.72M), and Paraguay ($7.9M).

In 2022, Brazil imported $4.71B in Vaccines, blood, antisera, toxins and cultures, mainly from Belgium ($1.11B), Switzerland ($717M), United States ($702M), Germany ($526M), and Ireland ($336M).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Brazil WERE (2021 - 2022):
China$149M (11.6k%)
Uruguay$14.7M (219%)
Japan$7.62M (3.51k%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Brazil WERE (2021 - 2022):
Germany-$11.5M (-54.3%)
France-$11M (-73.7%)
Sweden-$9.74M (-97.9%)

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, Brazil's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2022, Brazil's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Have questions, comments, or concerns?
Send us an e-mail: [email protected]
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with